Xuli Meng Selected Research

Xuli Meng Research Topics

12	Breast Neoplasms (Breast Cancer) 09/2022 - 09/2011
11	Neoplasms (Cancer) 09/2022 - 01/2018
4	Carcinogenesis 09/2022 - 09/2011
4	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2019
2	Triple Negative Breast Neoplasms 09/2022 - 06/2019
1	Hypoxia (Hypoxemia) 09/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Hyperglycemia 01/2021
1	Inflammation (Inflammations) 01/2021
1	Lymphatic Metastasis 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2019
1	Adenocarcinoma 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Infections 09/2011

4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2017
3	Long Noncoding RNAIBA 01/2021 - 06/2019
2	Biological ProductsIBA 09/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 09/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022
1	Photosensitizing Agents (Photosensitizers)IBA 09/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2022
1	rhodiolosideIBA 09/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Ubiquitin-Specific ProteasesIBA 01/2022
1	naringeninIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Competitive Endogenous RNAIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	tacrolimus binding protein 4 (FKBP52)IBA 01/2021
1	Caspase 9IBA 06/2019
1	Phosphotransferases (Kinase)IBA 02/2016
1	Pharmaceutical PreparationsIBA 02/2016
1	Proteins (Proteins, Gene)FDA Link 09/2011
1	Estrogen ReceptorsIBA 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 09/2011
1	Messenger RNA (mRNA)IBA 09/2011
1	Small Interfering RNA (siRNA)IBA 09/2011

4	Neoadjuvant Therapy 01/2022 - 01/2018
4	Drug Therapy (Chemotherapy) 01/2021 - 09/2017
2	Radiotherapy 02/2022 - 01/2018
1	Phototherapy (Light Therapy) 09/2022
1	Photochemotherapy (Photodynamic Therapy) 09/2022
1	Immunotherapy 01/2022
1	Therapeutics 02/2016